|
Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
| 2016-2020 | 457 | - | - | 291 | 63.7 | 71 | 15.5 | 49 | 10.7 | 46 | 10.1 |
| 2015-2019 | 441 | - | - | 270 | 61.2 | 67 | 15.2 | 48 | 10.9 | 56 | 12.7 |
| 2014-2018 | 388 | - | - | 234 | 60.3 | 57 | 14.7 | 42 | 10.8 | 55 | 14.2 |
| 2013-2017 | 349 | - | - | 207 | 59.3 | 53 | 15.2 | 30 | 8.6 | 59 | 16.9 |
| 2012-2016 | 341 | - | - | 216 | 63.3 | 49 | 14.4 | 25 | 7.3 | 51 | 15.0 |
| 2011-2015 | 354 | - | - | 249 | 70.3 | 48 | 13.6 | 19 | 5.4 | 38 | 10.7 |
| 2010-2014 | 360 | - | - | 267 | 74.2 | 51 | 14.2 | 13 | 3.6 | 29 | 8.1 |
| 2009-2013 | 381 | - | - | 287 | 75.3 | 54 | 14.2 | 10 | 2.6 | 30 | 7.9 |
| 2008-2012 | 416 | - | - | 316 | 76.0 | 54 | 13.0 | 13 | 3.1 | 33 | 7.9 |
| 2007-2011 | 451 | - | - | 342 | 75.8 | 62 | 13.7 | 11 | 2.4 | 36 | 8.0 |
| 2006-2010 | 481 | - | - | 365 | 75.9 | 62 | 12.9 | 14 | 2.9 | 40 | 8.3 |
| 2005-2009 | 499 | - | - | 379 | 76.0 | 57 | 11.4 | 20 | 4.0 | 43 | 8.6 |
| 2004-2008 | 516 | - | - | 388 | 75.2 | 59 | 11.4 | 23 | 4.5 | 46 | 8.9 |
| 2003-2007 | 527 | - | - | 398 | 75.5 | 60 | 11.4 | 22 | 4.2 | 47 | 8.9 |
| 2002-2006 | 534 | 1 | 0.2 | 404 | 75.7 | 54 | 10.1 | 24 | 4.5 | 51 | 9.6 |
| 2001-2005 | 527 | 3 | 0.6 | 384 | 72.9 | 61 | 11.6 | 23 | 4.4 | 56 | 10.6 |
| 2000-2004 | 514 | 3 | 0.6 | 367 | 71.4 | 62 | 12.1 | 21 | 4.1 | 61 | 11.9 |
| 1999-2003 | 506 | 5 | 1.0 | 339 | 67.0 | 68 | 13.4 | 23 | 4.5 | 71 | 14.0 |
| 1998-2002 | 498 | 5 | 1.0 | 333 | 66.9 | 60 | 12.0 | 26 | 5.2 | 74 | 14.9 |
| 1997-2001 | 463 | 4 | 0.9 | 301 | 65.0 | 56 | 12.1 | 27 | 5.8 | 75 | 16.2 |
| 1996-2000 | 421 | 3 | 0.7 | 272 | 64.6 | 46 | 10.9 | 25 | 5.9 | 75 | 17.8 |
| 1995-1999 | 425 | 3 | 0.7 | 280 | 65.9 | 45 | 10.6 | 24 | 5.6 | 73 | 17.2 |
| 1994-1998 | 458 | 2 | 0.4 | 300 | 65.5 | 51 | 11.1 | 23 | 5.0 | 82 | 17.9 |
| 1993-1997 | 490 | 2 | 0.4 | 292 | 59.6 | 72 | 14.7 | 21 | 4.3 | 103 | 21.0 |
| 1992-1996 | 565 | 2 | 0.4 | 313 | 55.4 | 90 | 15.9 | 27 | 4.8 | 133 | 23.5 |
| 1991-1995 | 624 | 2 | 0.3 | 353 | 56.6 | 98 | 15.7 | 36 | 5.8 | 135 | 21.6 |
| 1990-1994 | 621 | 2 | 0.3 | 327 | 52.7 | 104 | 16.7 | 37 | 6.0 | 151 | 24.3 |
| 1989-1993 | 568 | 1 | 0.2 | 302 | 53.2 | 82 | 14.4 | 38 | 6.7 | 145 | 25.5 |
| 1988-1992 | 512 | 1 | 0.2 | 265 | 51.8 | 64 | 12.5 | 39 | 7.6 | 143 | 27.9 |
| 1987-1991 | 427 | 1 | 0.2 | 218 | 51.1 | 51 | 11.9 | 38 | 8.9 | 119 | 27.9 |
| 1986-1990 | 343 | - | - | 153 | 44.6 | 42 | 12.2 | 35 | 10.2 | 113 | 32.9 |
| 1985-1989 | 309 | - | - | 146 | 47.2 | 38 | 12.3 | 35 | 11.3 | 90 | 29.1 |
| Notes: |
|---|
|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
| Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
| Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
| Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
| COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
| Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
|
Last Updated : April 13, 2023 |